Indications
As an aid in the management of overweight and obesity in adult dogs. To be used as part of an overall weight-management programme that also includes appropriate dietary changes and exercise practice.
Composition
- Active substance
- dirlotapide
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Slentrol
- Active substance
- dirlotapide
- Group
- Veterinary medicines
- Marketing authorisation holder
- Zoetis Belgium SA
- Status
- Withdrawn
- EU authorisation
- 13 Apr 2007
- EMA product number
- EMEA/V/C/000116